PH12013502597A1 - Pyrazole derivatives useful as aldosterone synthase inhibitors - Google Patents
Pyrazole derivatives useful as aldosterone synthase inhibitorsInfo
- Publication number
- PH12013502597A1 PH12013502597A1 PH1/2013/502597A PH12013502597A PH12013502597A1 PH 12013502597 A1 PH12013502597 A1 PH 12013502597A1 PH 12013502597 A PH12013502597 A PH 12013502597A PH 12013502597 A1 PH12013502597 A1 PH 12013502597A1
- Authority
- PH
- Philippines
- Prior art keywords
- synthase inhibitors
- aldosterone synthase
- pyrazole derivatives
- derivatives useful
- methods
- Prior art date
Links
- 229940123338 Aldosterone synthase inhibitor Drugs 0.000 title abstract 2
- 150000003217 pyrazoles Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161496657P | 2011-06-14 | 2011-06-14 | |
| US201161506349P | 2011-07-11 | 2011-07-11 | |
| PCT/US2012/041212 WO2012173849A1 (en) | 2011-06-14 | 2012-06-07 | Pyrazole derivatives useful as aldosterone synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12013502597A1 true PH12013502597A1 (en) | 2018-04-11 |
Family
ID=46317515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2013/502597A PH12013502597A1 (en) | 2011-06-14 | 2012-06-07 | Pyrazole derivatives useful as aldosterone synthase inhibitors |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US8778984B2 (https=) |
| EP (1) | EP2721009B1 (https=) |
| JP (1) | JP5890012B2 (https=) |
| KR (1) | KR101555119B1 (https=) |
| CN (1) | CN103596930B (https=) |
| AR (1) | AR086665A1 (https=) |
| AU (1) | AU2012271023A1 (https=) |
| BR (1) | BR112013031873A2 (https=) |
| CA (1) | CA2836804C (https=) |
| CL (1) | CL2013003536A1 (https=) |
| CO (1) | CO6821955A2 (https=) |
| CR (1) | CR20130601A (https=) |
| CY (1) | CY1116687T1 (https=) |
| DK (1) | DK2721009T3 (https=) |
| DO (1) | DOP2013000284A (https=) |
| EA (1) | EA201391655A1 (https=) |
| EC (1) | ECSP13013080A (https=) |
| ES (1) | ES2548210T3 (https=) |
| GT (1) | GT201300307A (https=) |
| HR (1) | HRP20150939T1 (https=) |
| HU (1) | HUE026461T2 (https=) |
| IL (1) | IL229485A0 (https=) |
| ME (1) | ME02223B (https=) |
| MX (1) | MX336042B (https=) |
| PE (1) | PE20140606A1 (https=) |
| PH (1) | PH12013502597A1 (https=) |
| PL (1) | PL2721009T3 (https=) |
| PT (1) | PT2721009E (https=) |
| RS (1) | RS54269B1 (https=) |
| SG (1) | SG194822A1 (https=) |
| SI (1) | SI2721009T1 (https=) |
| TW (1) | TWI518073B (https=) |
| WO (1) | WO2012173849A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6596417B2 (ja) * | 2014-07-04 | 2019-10-23 | 日本たばこ産業株式会社 | インドール化合物の製造方法 |
| CN108586221B (zh) * | 2018-06-26 | 2021-03-02 | 常州制药厂有限公司 | 用于制备替卡格雷的中间体及其制备方法 |
| CN112409432B (zh) * | 2020-11-16 | 2023-07-07 | 陕西理工大学 | 一种依西美坦的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57165369A (en) | 1981-04-06 | 1982-10-12 | Teijin Ltd | Pyrazole derivative and its preparation |
| US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US5057521A (en) | 1988-10-26 | 1991-10-15 | Ciba-Geigy Corporation | Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism |
| GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| WO2007111175A1 (ja) | 2006-03-17 | 2007-10-04 | Ngk Insulators, Ltd. | 目封止ハニカム構造体の製造方法 |
| ES2472446T3 (es) | 2009-11-30 | 2014-07-01 | Novartis Ag | Derivados de imidazol como inhibidores de aldosterona sintasa |
| JP5602250B2 (ja) | 2010-01-14 | 2014-10-08 | ノバルティス アーゲー | 副腎ホルモン修飾剤の使用 |
-
2012
- 2012-06-04 AR ARP120101967A patent/AR086665A1/es unknown
- 2012-06-04 TW TW101120004A patent/TWI518073B/zh not_active IP Right Cessation
- 2012-06-07 RS RS20150619A patent/RS54269B1/sr unknown
- 2012-06-07 SG SG2013082367A patent/SG194822A1/en unknown
- 2012-06-07 ES ES12727984.2T patent/ES2548210T3/es active Active
- 2012-06-07 PH PH1/2013/502597A patent/PH12013502597A1/en unknown
- 2012-06-07 JP JP2014515877A patent/JP5890012B2/ja not_active Expired - Fee Related
- 2012-06-07 PT PT127279842T patent/PT2721009E/pt unknown
- 2012-06-07 DK DK12727984.2T patent/DK2721009T3/en active
- 2012-06-07 AU AU2012271023A patent/AU2012271023A1/en not_active Abandoned
- 2012-06-07 PE PE2013002810A patent/PE20140606A1/es not_active Application Discontinuation
- 2012-06-07 HR HRP20150939TT patent/HRP20150939T1/hr unknown
- 2012-06-07 EP EP12727984.2A patent/EP2721009B1/en active Active
- 2012-06-07 EA EA201391655A patent/EA201391655A1/ru unknown
- 2012-06-07 PL PL12727984T patent/PL2721009T3/pl unknown
- 2012-06-07 WO PCT/US2012/041212 patent/WO2012173849A1/en not_active Ceased
- 2012-06-07 US US13/490,530 patent/US8778984B2/en not_active Expired - Fee Related
- 2012-06-07 ME MEP-2015-131A patent/ME02223B/me unknown
- 2012-06-07 CN CN201280028717.6A patent/CN103596930B/zh not_active Expired - Fee Related
- 2012-06-07 HU HUE12727984A patent/HUE026461T2/en unknown
- 2012-06-07 KR KR1020137032885A patent/KR101555119B1/ko not_active Expired - Fee Related
- 2012-06-07 SI SI201230283T patent/SI2721009T1/sl unknown
- 2012-06-07 MX MX2013014790A patent/MX336042B/es unknown
- 2012-06-07 BR BR112013031873A patent/BR112013031873A2/pt not_active IP Right Cessation
- 2012-06-07 CA CA2836804A patent/CA2836804C/en not_active Expired - Fee Related
-
2013
- 2013-11-18 CR CR20130601A patent/CR20130601A/es unknown
- 2013-11-18 IL IL229485A patent/IL229485A0/en unknown
- 2013-12-02 DO DO2013000284A patent/DOP2013000284A/es unknown
- 2013-12-10 CL CL2013003536A patent/CL2013003536A1/es unknown
- 2013-12-11 CO CO13290174A patent/CO6821955A2/es active IP Right Grant
- 2013-12-11 GT GT201300307A patent/GT201300307A/es unknown
- 2013-12-13 EC ECSP13013080 patent/ECSP13013080A/es unknown
-
2015
- 2015-09-11 CY CY20151100789T patent/CY1116687T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2011000673A1 (en) | Bace inhibitors | |
| AU2012213775A8 (en) | 7-azaindole derivatives | |
| WO2011153157A3 (en) | Benzoquinolone inhibitors of vmat2 | |
| UA117122C2 (uk) | Хінолонові похідні | |
| GEP201706688B (en) | Cdk8/cdk19 selective inhibitors and their use in anti- metastatic and chemopreventative methods for cancer | |
| MY177344A (en) | Compounds and their methods of use | |
| MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
| ZA201301799B (en) | Process for the preparation of pan-cdk inhibitors of the formula (i),and intermediates of the preparation | |
| MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
| JO3115B1 (ar) | مركبات بيريدازينون واستخدامها كمثبطات daao | |
| PH12014501258A1 (en) | Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof | |
| UA111198C2 (uk) | Похідні 1-феніл-2-піридинілалкільних спиртів як інгібітори фосфодіестерази | |
| EA201491376A1 (ru) | Производные 1h-пирроло[2,3-b]пиридина и их применение в качестве ингибиторов киназы | |
| IN2015DN01151A (https=) | ||
| ZA201306416B (en) | Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) | |
| AU2015292632B2 (en) | Aldosterone synthase inhibitors | |
| WO2011123524A3 (en) | Macrolide inhibitors of mtor | |
| TN2013000420A1 (en) | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors | |
| AU2016204389A1 (en) | Kinase inhibitors for the treatment of cancer | |
| PH12013502597A1 (en) | Pyrazole derivatives useful as aldosterone synthase inhibitors | |
| AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
| MX2014002378A (es) | Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma. | |
| TN2013000456A1 (en) | Pyrazole derivatives useful as aldosterone synthase inhibitors | |
| UA110829C2 (uk) | Похідні піразолу, придатні як інгібітори альдостеронсинтази | |
| MX2014008856A (es) | Derivados de imidazolilcetona como inhibidores de aldosterona sintasa. |